Intrinsiqq
C4 Therapeutics Inc. logo

C4 Therapeutics Inc. Insider Trading

CCCC

⊜ Compare
Last 12 months

Insiders sold 22K and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. The last open-market buy by an executive or director was in Feb 2023.

Net open-market
−22K
0 buys · 1 sale
Under a 10b5-1 plan
0%
of the value sold
Insiders who bought / sold
0 / 1
executives and directors
Last open-market buy
Feb 2023
Feb 8, 2023

Get an email when CCCC's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Jan 16No plan
    Leonard Reyno
    Chief Medical Officer · sold 10,000 at $2.22
    22K
    6.0% of stake
  • Feb 14, 2025 – Feb 18, 202510b5-1 plan
    Scott N Boyle
    Chief Business Officer · sold 1,159 at avg $3.15
    4K
    1.1% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch CCCC, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with CCCC

CompareIntrinsic value
SGMOSangamo Therapeutics Inc.
$0.12-0.20%10
VYGRVoyager Therapeutics Inc.
$1.87+2.19%10
SCLXScilex Holding Company
$1.83-1.08%0
EDITEditas Medicine Inc.
$2.73+5.00%40
GLUEMonte Rosa Therapeutics, Inc.
$10.82+3.94%10
MGXMetagenomi, Inc.
$0.79+3.95%10
DTILPrecision Biosciences Inc.
$7.89+13.20%48
ATRAAtara Biotherapeutics, Inc.
$8.37+2.07%15

Held by ETFs

CCCC is in 12 US ETFs. The largest of them, with CCCC's weight in each:

Spot a number that looks wrong? Check it in CCCC's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing CCCC

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.